Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis

Thorax

Volumn 55, Issue 8, 2000, Pages 717-719

  Hafeez, I ^a   Muers, M F ^b   Murphy, S A ^c   Evans, E G V ^d   Barton, R C ^d   McWhinney, P ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aspergillosis; Chronic necrotising aspergillosis; Corticosteroids; Mycosis; Non tuberculous mycobacteria

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; ITRACONAZOLE; PREDNISOLONE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RIFATER; STEROID;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LUNG ASPERGILLOSIS; LUNG INFECTION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM MALMOENSE; NECROSIS; PRIORITY JOURNAL;

AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; HUMANS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, ATYPICAL; TREATMENT OUTCOME;

EID: 0033910349     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.8.717     Document Type: Article

References (24)

1. 1 Falkinham J. Epidemiology of infection by non-tuberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215.
2. 2 Jenkins PA. The epidemiology of opportunistic mycobacterial infection in Wales, 1952-1978. Rev Infect Dis 1981;3:1021-3.
3. 3 Yates MD, Grange JM, Collins CH. The nature of mycobacterial disease in southeast England, 1977-84. J Epidemiol Community Health 1986;40:295-300.
4. 4 American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997;156 : S1-25.
5. 5 France AJ, Mcleod DT, Calder MA, et al. Mycobacterium malmoense infections in Scotland: an increasing problem. Thorax 1987;42:592-5.
6. 6 Bollert FGE, Sime PJ, MacNee W, et al. Pulmonary Mycobacterium malmoense and Aspergillus infection: a fatal combination. Thorax 1994;49:521-2.
7. 7 Debieuvre D, Dubiez JC, Dalphin JC, et al. Infection pulmonaire á Mycobacteriun malmoense compliquée d'un aspergillome. Med Mal Infect 1993;23:374-6.
8. 8 Johnston IDA. Mycobacterium xenopi infection and aspergilloma. Tubercle 1988;69:139-44.
9. 9 Maliwan N, Zvetina JR. Pulmonary mycetoma following Mycobacterium kansasii infection. Arch Intern Med 1985; 145:2180-3.
10. 10 Binder RE, Faling JF, Pugatch RD, et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982;61:109-24.
11. 11 Gefter WB, Weinrad TR, Epstein DM, et al. Semi-invasive pulmonary aspergillosis. Radiology 1981;140:313-21.
12. 12 Saraceno JL, Phelps DT, Futerfas R, et al. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997;112:541-8.
13. 13 Yousem SA. The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis. Human Pathol 1997; 28:650-6.
14. 14 Scadding JG. The bronchi in allergic aspergillosis. Scand J Rispir Dis 1967;48:372-7.
15. 15 Hilvering C, Stevens EAM, Orie NGM. Fever in aspergillus mycetoma. Thorax 1970;25:19-24.
16. 16 Viviani MA, Tortorano AM, Pagano A, et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol 1990;23:587-93.
17. 17 Caras WE, Pluss JL. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy. Mayo Clin Proc 1996;71:25-30.
18. 18 Caras WE. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1998;113:852-3.
19. 19 Lefort A, Launay O, Carbon C. Uveitis associated with rifabutin prophylaxis and itraconazole therapy. Ann Intern Med 1996;125:939-10.
20. 20 Strolin Benedetti M. Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs. Pharmacol Res 1995;32:177-87.
21. 21 Smith JA, Hardin TC, Patterson TF, et al. Rifabutin decreases itraconazole plasma levels in patients with HIV infection. 2nd National Conference on Human Retroviruses and Related Infections, Washington, 29 January-2 February 1995, abstract 126.
22. 22 Daly RC, Pairolero JM, Trasket VF, et al. Pulmonary aspergilloma. Results of surgical treatment. J Thorac Cardiovasc Surg 1986;92:981-8.
23. 23 McWhinney PH, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in the bone marrow transplantation: 13 years experience. Clin Infect Dis 1993;17:397-404.
24. 24 Giron J, Poey C, Fadjet P, et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol 1998;28:235-42.